FGF23 and Sepsis: Therefore, in order to improve sepsis survival, new therapeutic strategies are needed to target the upstream mechanisms that lead to the suppressed production of 1,25(OH)2D. Such upstream mechanisms include decreased production of IGF-1, increased production of FGF-23, and kidney failure.